Promoter Sequence Optimization for Corynebacterium Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for enhancing the production of fine chemicals and proteins in Corynebacterium species, such as Corynebacterium glutamicum, are limited in their ability to regulate gene expression efficiently, particularly in terms of transcription and translation rates, which affects productivity and yield.
Innovation Solution
The use of novel nucleic acid sequences with promoter activity, specifically the nucleic acid sequence SEQ. ID. NO. 1 and its derivatives, to regulate gene transcription and expression by influencing transcription and translation rates, thereby enhancing the production of biosynthetic products like amino acids, vitamins, and proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional promoter sequences are used to drive gene expression in Corynebacterium species, then basic transcription occurs, but the transcription rate and expression level remain limited and insufficient for high productivity
Solution Approach 1:
The patent applies parameter changes by systematically modifying promoter sequence parameters including GC content (optimized to 40-60%), length of -10 and -35 regions, spacing between promoter elements, and homopolymer run lengths. These parameter optimizations transform a basic promoter into a high-expression promoter that can drive significantly higher transcription rates and biosynthetic product yields in Corynebacterium species
2Productivity
If gene expression is increased to enhance productivity, then more biosynthetic product is produced, but the metabolic burden on the microorganism increases affecting growth and stability
Solution Approach 1:
The patent employs dynamics by creating inducible and regulatable expression systems where promoter activity can be dynamically adjusted in response to metabolic state, growth phase, or external inducers. This allows the system to optimize between growth and production phases, reducing metabolic burden during growth while enabling high productivity during production, thereby maintaining metabolic stability
Solution Approach 2:
The patent implements periodic action through growth-phase-dependent promoter expression patterns, where expression is modulated according to the metabolic state of the organism. This periodic regulation allows the microorganism to allocate resources appropriately between growth and product formation, preventing metabolic overload and maintaining system reliability
3Productivity
If strong constitutive promoters are used to maximize expression, then high transcription rates are achieved, but expression cannot be regulated in response to metabolic conditions or growth phase
Solution Approach 1:
The patent achieves universality by designing promoter systems that can function in multiple modes: as strong constitutive promoters for maximum expression, as inducible promoters for controlled activation, or as growth-phase-dependent promoters for automatic regulation. This multi-functionality allows the same promoter architecture to adapt to different experimental and industrial requirements, providing both high productivity and regulatory flexibility
Data Source
AI summary
The present invention relates to the use of nucleic acid sequences for regulating the transcription and expression of genes, the novel promoters and expression units themselves, methods for altering or causing the transcription rate and/or expression rate of genes, expression cassettes comprising the expression units, genetically modified microorganisms with altered or caused transcription rate and/or expression rate, and methods for preparing biosynthetic products by cultivating the genetically modified microorganisms.